Loading page...
Loading page...
AdBio SAS · Multi-Country
Advent France Biotechnology Seed Fund I is a life sciences venture fund managed by AdBio (formerly Advent France Biotechnology), based in Paris. Launched in 2017 and closed at around EUR 68M, it backs early-stage, therapeutics-focused biotech companies across Europe.
Choose your AI and follow the walkthrough. Your free EUACC account connects the two.
Illustrated walkthrough
https://www.euacc.ai/api/mcpWorks on every Claude plan, including Free (one custom connector). On Team and Enterprise, an Owner adds it.
On a phone, add it at claude.ai in your browser. It then shows up in the Claude app the next time you sign in.
Use EUACC to explore “Advent france biotechnology seed fund i” (https://www.euacc.ai/investors/advent-france-biotechnology-seed-fund-i). Help me assess investor fit and prepare questions using the available fund profiles. Cite the available sources and flag missing or outdated information.